These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 7517682)
21. Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis. Sperr WR; Escribano L; Jordan JH; Schernthaner GH; Kundi M; Horny HP; Valent P Leuk Res; 2001 Jul; 25(7):529-36. PubMed ID: 11377677 [TBL] [Abstract][Full Text] [Related]
22. [The mast cell and its pathology. 2: Histopathology of mastocytosis]. Lortholary O; Audouin J; Le Tourneau A; Diebold J Ann Pathol; 1991; 11(2):92-100. PubMed ID: 2053996 [No Abstract] [Full Text] [Related]
25. Heterogeneity of mast cells in mastocytosis and inhibitory effect of ketotifen and ranitidine on indolent systemic mastocytosis. Kurosawa M; Amano H; Kanbe N; Akimoto S; Takeuchi Y; Yamashita T; Hashimoto T; Kurimoto F; Miyachi Y J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S25-32. PubMed ID: 9440541 [TBL] [Abstract][Full Text] [Related]
26. [Morphology of mastocytosis]. Persina IS; Kasimov N Arkh Patol; 1987; 49(7):26-32. PubMed ID: 3662856 [TBL] [Abstract][Full Text] [Related]
27. Mast-cell phenotype in indolent forms of mastocytosis. Ultrastructural features, fluorescence detection of avidin binding, and immunofluorescent determination of chymase, tryptase, and carboxypeptidase. Weidner N; Horan RF; Austen KF Am J Pathol; 1992 Apr; 140(4):847-57. PubMed ID: 1562049 [TBL] [Abstract][Full Text] [Related]
28. Pathogenesis and Pathology of Mastocytosis. Metcalfe DD; Mekori YA Annu Rev Pathol; 2017 Jan; 12():487-514. PubMed ID: 28135563 [TBL] [Abstract][Full Text] [Related]
29. Biology, classification and treatment of human mastocytosis. Valent P Wien Klin Wochenschr; 1996; 108(13):385-97. PubMed ID: 8766423 [TBL] [Abstract][Full Text] [Related]
30. Stem cell factor-induced bone marrow mast cell hyperplasia mimicking systemic mastocytosis (SM): histopathologic and morphologic evaluation with special reference to recently established SM-criteria. Jordan JH; Schernthaner GH; Fritsche-Polanz R; Sperr WR; Födinger M; Chott A; Geissler K; Lechner K; Horny HP; Valent P Leuk Lymphoma; 2002 Mar; 43(3):575-82. PubMed ID: 12002761 [TBL] [Abstract][Full Text] [Related]
35. Fibrous mastocytoma in a patient with generalized cutaneous mastocytosis. Wood C; Sina B; Webster CG; Kurgansky D; Drachenberg CB; Reedy EA J Cutan Pathol; 1992 Apr; 19(2):128-33. PubMed ID: 1375950 [TBL] [Abstract][Full Text] [Related]
36. Update on Mastocytosis (Part 1): Pathophysiology, Clinical Features, and Diagnosis. Azaña JM; Torrelo A; Matito A Actas Dermosifiliogr; 2016; 107(1):5-14. PubMed ID: 26546030 [TBL] [Abstract][Full Text] [Related]
37. Southwestern Internal Medicine Conference: mastocytosis: developments during the past decade. Gruchalla RS Am J Med Sci; 1995 Jun; 309(6):328-38. PubMed ID: 7771504 [TBL] [Abstract][Full Text] [Related]
38. Drug allergy in mastocytosis. Bonadonna P; Lombardo C Immunol Allergy Clin North Am; 2014 May; 34(2):397-405. PubMed ID: 24745682 [TBL] [Abstract][Full Text] [Related]